Document:

THESE  SECURITIES  AND THE  UNDERLYING  SHARES  OF  COMMON  STOCK  HAVE NOT BEEN
REGISTERED  WITH  THE  SECURITIES  AND  EXCHANGE  COMMISSION  OR THE  SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION  FROM  REGISTRATION  UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY,
MAY  NOT BE  OFFERED  OR  SOLD  EXCEPT  PURSUANT  TO AN  EFFECTIVE  REGISTRATION
STATEMENT  UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE  EXEMPTION FROM,
OR IN A  TRANSACTION  NOT  SUBJECT  TO,  THE  REGISTRATION  REQUIREMENTS  OF THE
SECURITIES  ACT AND IN  ACCORDANCE  WITH  APPLICABLE  STATE  SECURITIES  LAWS AS
EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE  TRANSFEROR  TO SUCH EFFECT,  THE
SUBSTANCE  OF  WHICH  SHALL  BE  REASONABLY  ACCEPTABLE  TO THE  COMPANY.  THESE
SECURITIES  MAY BE PLEDGED IN CONNECTION  WITH A BONA FIDE MARGIN ACCOUNT WITH A
REGISTERED  BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL  INSTITUTION THAT IS AN
"ACCREDITED INVESTOR" AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT.

                          COMMON STOCK PURCHASE WARRANT

                   To Purchase [XX] Shares of Common Stock of

                                 ROOMLINX, INC.

                  THIS COMMON STOCK PURCHASE  WARRANT  CERTIFIES that, for value
received,  [__________] (the "Holder"),  is entitled, upon the terms and subject
to the limitations on exercise and the conditions  hereinafter set forth, at any
time on or after the date hereof (the "Initial  Exercise  Date") and on or prior
to the close of business on the fifth  anniversary of the Initial  Exercise Date
(the "Termination Date") but not thereafter,  to subscribe for and purchase from
RoomLinX,  Inc., a Nevada  corporation (the  "Company"),  up to [XX] shares (the
"Warrant  Shares") of Common  Stock,  par value $.001 per share,  of the Company
(the  "Common  Stock").  The  purchase  price of one share of Common  Stock (the
"Exercise  Price")  under this Warrant  shall be $0.075,  subject to  adjustment
hereunder.  The  Exercise  Price and the number of Warrant  Shares for which the
Warrant is  exercisable  shall be  subject to  adjustment  as  provided  herein.
Capitalized  terms used and not otherwise defined herein shall have the meanings
set forth in the Securities Purchase Agreement (the "Purchase Agreement"), dated
March 2, 2005, by and between the Company and the original holder hereof.

<PAGE>

         1.  Title to  Warrant.  Prior to the  Termination  Date and  subject to
compliance with applicable laws and Section 7 of this Warrant,  this Warrant and
all rights  hereunder  are  transferable,  in whole or in part, at the office or
agency of the  Company by the Holder in person or by duly  authorized  attorney,
upon surrender of this Warrant  together with the Assignment Form annexed hereto
properly  endorsed.  The transferee shall sign an investment  letter in form and
substance reasonably satisfactory to the Company.

         2.  Authorization  of Shares.  The Company  covenants  that all Warrant
Shares which may be issued upon the exercise of the purchase rights  represented
by this Warrant will, upon exercise of the purchase  rights  represented by this
Warrant in accordance with the provisions of this Warrant,  be duly  authorized,
validly issued,  fully paid and nonassessable and free from all taxes, liens and
charges  in  respect of the issue  thereof  (other  than taxes in respect of any
transfer occurring contemporaneously with such issue).

         3. Exercise of Warrant.

                  (a) Except as  provided  in Section 4 herein,  exercise of the
         purchase rights  represented by this Warrant may be made at any time or
         times on or after  the  Initial  Exercise  Date  and on or  before  the
         Termination  Date by the  surrender  of this  Warrant and the Notice of
         Exercise  Form  annexed  hereto  duly  executed,  at the  office of the
         Company  (or such  other  office  or agency  of the  Company  as it may
         designate by notice in writing to the registered  Holder at the address
         of such Holder  appearing on the books of the Company) and upon payment
         of the Exercise Price of the shares thereby  purchased by wire transfer
         or  cashier's  check  drawn  on a United  States  bank or by means of a
         cashless  exercise  pursuant  to  Section  3(c),  the  Holder  shall be
         entitled to receive a certificate  for the number of Warrant  Shares so
         purchased.   Certificates  for  shares  purchased  hereunder  shall  be
         delivered to the Holder within three (3) trading days after the date on
         which this Warrant shall have been exercised as aforesaid. This Warrant
         shall  be  deemed  to have  been  exercised  and  such  certificate  or
         certificates  shall be deemed to have been  issued,  and  Holder or any
         other person so  designated to be named therein shall be deemed to have
         become a holder of record of such  shares for all  purposes,  as of the
         date the  Warrant has been  exercised  by payment to the Company of the
         Exercise Price and all taxes required to be paid by the Holder, if any,
         pursuant to Section 5 prior to the issuance of such  shares,  have been
         paid. If the Company  fails to deliver to the Holder a  certificate  or
         certificates  representing  the Warrant Shares pursuant to this Section
         3(a) by the third  trading  day after  the date of  exercise,  then the
         Holder will have the right to rescind such exercise.

                  (b) If this Warrant  shall have been  exercised  in part,  the
         Company  shall,   at  the  time  of  delivery  of  the  certificate  or
         certificates  representing  Warrant Shares,  provided that this Warrant
         has been  surrendered  to the Company,  deliver to Holder a new Warrant
         evidencing  the rights of Holder to purchase  the  unpurchased  Warrant
         Shares called for by this Warrant, which new Warrant shall in all other
         respects be identical with this Warrant.

                  (c) At any  time  following  the  date  of  issuance  of  this
         Warrant,  this Warrant may also be exercised,  at any time prior to the
         Termination Date, by means of a "cashless exercise" in which the Holder

                                      -2-
<PAGE>

         shall be  entitled to receive a  certificate  for the number of Warrant
         Shares equal to the quotient  obtained by dividing  [(A-B) (X)] by (A),
         where:

             (A)  =  the closing  bid price on the trading day  preceding
                     the date of such election;

             (B)  =   the Exercise Price of the Warrants, as adjusted; and

             (X)  =   the number of Warrant Shares  issuable upon exercise
                     of the Warrants in  accordance  with the terms of this
                     Warrant  by means  of a cash  exercise  rather  than a
                     cashless exercise.

                  (d) If at any time following the Initial Exercise Date (a) the
         Company's Common Stock is then publicly traded, (b) the VWAP for any 15
         consecutive  trading days is at least $0.60  (subject to  adjustment in
         connection  with any forward or reverse  stock split,  stock  dividend,
         merger,  reorganization or similar event) (the "Warrant Forced Exercise
         Triggering  Period")  and  (c)  there  is  an  effective   registration
         statement  covering the resale of the Warrant Shares, the Company shall
         be entitled to force the Holder to exercise this  Warrant,  in whole or
         in part, at the then effective Exercise Price. In the event the Company
         elects to force exercise of this Warrant, the Company shall provide the
         Holder with notice of such forced exercise within 5 days after the last
         day of the Warrant  Forced  Exercise  Triggering  Period  (the  "Forced
         Exercise  Notice").  The Forced  Exercise  Notice  shall be sent to the
         Holder in  accordance  with the terms  set forth in  Section  17(d) and
         shall set forth the date on which the forced exercise shall occur, such
         date to be no less  than 30 days from the date of the  Forced  Exercise
         Notice (the "Forced Exercise Date"). Prior to the Forced Exercise Date,
         the Holder shall have the right to exercise  this Warrant in accordance
         with the terms  hereof.  Upon the Forced  Exercise  Date,  all Warrants
         noticed for forced exercise that have not theretofore been exercised by
         the  Holder  shall,  upon  payment  of  the  aggregate  exercise  price
         therefor, be exercised and the Company shall issued Warrant Shares upon
         payment of the exercise price therefor.

                  As  used  herein,  "VWAP"  means,  for  any  date,  the  price
         determined by the first of the following  clauses that applies:  (a) if
         the  Common  Stock is then  listed or quoted on a trading  market,  the
         daily volume  weighted  average price of the Common Stock for such date
         (or the  nearest  preceding  date) on the  trading  market on which the
         Common  Stock  is then  listed  or  quoted  as  reported  by  Bloomberg
         Financial L.P.  (based on a trading day from 9:30 a.m.  Eastern Time to
         4:02 p.m.  Eastern Time); (b) if the Common Stock is not then listed or
         quoted on a trading  market and if prices for the Common Stock are then
         quoted on the OTC Bulletin Board,  the volume weighted average price of
         the Common Stock for such date (or the nearest  preceding  date) on the
         OTC  Bulletin  Board;  (c) if the  Common  Stock is not then  listed or
         quoted on the OTC Bulletin Board and if prices for the Common Stock are
         then  reported in the "Pink Sheets"  published by the Pink Sheets,  LLC
         (or a similar  organization  or agency  succeeding  to its functions of
         reporting  prices),  the most  recent bid price per share of the Common
         Stock so reported;  or (d) in all other cases, the fair market value of
         a share of  Common  Stock as  determined  by an  independent  appraiser
         selected in good faith by the  Investors and  reasonably  acceptable to
         the Company.

                                      -3-
<PAGE>

         4. No  Fractional  Shares  or  Scrip.  No  fractional  shares  or scrip
representing  fractional  shares  shall  be  issued  upon the  exercise  of this
Warrant.  As to any fraction of a share which Holder would otherwise be entitled
to purchase  upon such  exercise,  the Company  shall pay a cash  adjustment  in
respect of such final fraction in an amount equal to such fraction multiplied by
the Exercise Price.

         5. Charges,  Taxes and Expenses.  Issuance of certificates  for Warrant
Shares shall be made without  charge to the Holder for any issue or transfer tax
or other  incidental  expense in respect of the issuance of such  certificate to
the Holder,  all of which taxes and expenses  shall be paid by the Company,  and
such  certificates  shall be issued in the name of the Holder or in such name or
names as may be  directed by the Holder;  provided,  however,  that in the event
certificates  for Warrant  Shares are to be issued in a name other than the name
of the Holder,  this Warrant when  surrendered for exercise shall be accompanied
by the  Assignment  Form attached  hereto duly  executed by the Holder;  and the
Company may require, as a condition thereto,  the payment of a sum sufficient to
reimburse it for any transfer tax incidental thereto.

         6. Closing of Books.  The Company will not close its stockholder  books
or records in any manner  which  prevents the timely  exercise of this  Warrant,
pursuant to the terms hereof.

         7. Transfer, Division and Combination.

                  (a) Subject to compliance with any applicable  securities laws
         and the  conditions  set  forth in  Sections  1 and 7(e)  hereof,  this
         Warrant and all rights hereunder are transferable, in whole or in part,
         upon surrender of this Warrant at the principal  office of the Company,
         together with a written assignment of this Warrant substantially in the
         form  attached  hereto  duly  executed  by the  Holder  or its agent or
         attorney and funds  sufficient  to pay any transfer  taxes payable upon
         the making of such transfer. Upon such surrender and, if required, such
         payment,  the  Company  shall  execute  and  deliver a new  Warrant  or
         Warrants  in  the  name  of  the  assignee  or  assignees  and  in  the
         denomination   or   denominations   specified  in  such  instrument  of
         assignment,  and shall issue to the  assignor a new Warrant  evidencing
         the portion of this  Warrant not so assigned,  and this  Warrant  shall
         promptly  be  cancelled.  A  Warrant,  if  properly  assigned,  may  be
         exercised  by a new holder for the purchase of Warrant  Shares  without
         having a new Warrant issued.

                  (b)  This  Warrant  may be  divided  or  combined  with  other
         Warrants  upon  presentation  hereof  at the  aforesaid  office  of the
         Company,  together  with a  written  notice  specifying  the  names and
         denominations  in which new  Warrants  are to be issued,  signed by the
         Holder or its agent or  attorney.  Subject to  compliance  with Section
         7(a),  as to any  transfer  which may be involved  in such  division or
         combination,  the  Company  shall  execute and deliver a new Warrant or
         Warrants  in  exchange  for the  Warrant or  Warrants  to be divided or
         combined in accordance with such notice.

                  (c) The Company  shall  prepare,  issue and deliver at its own
         expense  (other than transfer  taxes) the new Warrant or Warrants under
         this Section 7.

                  (d) The Company agrees to maintain,  at its aforesaid  office,
         books for the  registration  and the  registration  of  transfer of the
         Warrants.

                                      -4-
<PAGE>

                  (e) If,  at the  time of the  surrender  of  this  Warrant  in
         connection  with any  transfer of this  Warrant,  the  transfer of this
         Warrant shall not be registered  pursuant to an effective  registration
         statement  under  the  Securities  Act  and  under   applicable   state
         securities or blue sky laws, the Company may require, as a condition of
         allowing  such  transfer,  (i) that the  Holder or  transferee  of this
         Warrant,  as the case may be, furnish to the Company a written  opinion
         of  counsel  (which  opinion  shall be in  form,  substance  and  scope
         customary  for opinions of counsel in comparable  transactions)  to the
         effect that such  transfer may be made without  registration  under the
         Securities Act and under  applicable  state securities or blue sky laws
         and (ii) that the  holder or  transferee  execute  and  deliver  to the
         Company an investment  letter in form and  substance  acceptable to the
         Company.

         8. No Rights as  Shareholder  until  Exercise.  This  Warrant  does not
entitle the Holder to any voting rights or other rights as a shareholder  of the
Company prior to the exercise hereof. Upon the surrender of this Warrant and the
payment of the aggregate  Exercise  Price (or by means of a cashless  exercise),
the  Warrant  Shares  so  purchased  shall be and be deemed to be issued to such
Holder as the record  owner of such  shares as of the close of  business  on the
later of the date of such surrender or payment.

         9. Loss,  Theft,  Destruction  or  Mutilation  of Warrant.  The Company
covenants that upon receipt by the Company of evidence  reasonably  satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock
certificate  relating  to the  Warrant  Shares,  and in case of  loss,  theft or
destruction,  of indemnity or security reasonably  satisfactory to it (which, in
the case of the  Warrant,  shall not include the posting of any bond),  and upon
surrender and cancellation of such Warrant or stock  certificate,  if mutilated,
the Company  will make and deliver a new  Warrant or stock  certificate  of like
tenor  and  dated  as of such  cancellation,  in lieu of such  Warrant  or stock
certificate.

         10. Saturdays, Sundays, Holidays, etc. If the last or appointed day for
the  taking of any action or the  expiration  of any right  required  or granted
herein shall be a Saturday,  Sunday or a legal holiday,  then such action may be
taken or such right may be exercised on the next  succeeding day not a Saturday,
Sunday or legal holiday.

         11. Adjustments of Exercise Price and Number of Warrant Shares. (a) The
number and kind of securities  purchasable upon the exercise of this Warrant and
the  Exercise  Price shall be subject to  adjustment  from time to time upon the
happening of any of the following.  In case the Company shall (i) pay a dividend
in shares of Common  Stock or make a  distribution  in shares of Common Stock to
holders of its outstanding  Common Stock, (ii) subdivide its outstanding  shares
of Common Stock into a greater number of shares,  (iii) combine its  outstanding
shares of Common Stock into a smaller number of shares of Common Stock,  or (iv)
issue any shares of its capital stock in a reclassification of the Common Stock,
then in each such case the number of Warrant Shares purchasable upon exercise of
this  Warrant  immediately  prior  thereto  shall be adjusted so that the Holder
shall be  entitled  to receive  the kind and  number of Warrant  Shares or other
securities  of the  Company  which it would have owned or have been  entitled to
receive had such  Warrant  been  exercised  in advance  thereof.  Upon each such
adjustment of the kind and number of Warrant  Shares or other  securities of the
Company which are purchasable hereunder, the Holder shall thereafter be entitled
to purchase the number of Warrant Shares or other securities resulting from such
adjustment at an Exercise Price per Warrant Share or other security  obtained by

                                      -5-
<PAGE>

multiplying the Exercise Price in effect immediately prior to such adjustment by
the number of Warrant Shares  purchasable  pursuant hereto  immediately prior to
such adjustment and dividing by the number of Warrant Shares or other securities
of the Company  resulting from such  adjustment.  An adjustment made pursuant to
this paragraph shall become  effective  immediately  after the effective date of
such event retroactive to the record date, if any, for such event.

                  (b) If the Company at any time prior to the 60th day following
the  consummation  of a  subsequent  financing  by the  Company  with gross cash
proceeds of at least  $3,000,000 (the "Qualified  Offering")  shall issue, or be
deemed to have issued (a  "Triggering  Issuance"),  Additional  Shares of Common
Stock (as hereinafter  defined) without  consideration or for  consideration per
share of  Common  Stock  less  than  the then  applicable  Exercise  Price  (the
"Dilutive Price") in effect  immediately prior to such issuance,  then forthwith
upon the occurrence of any such event (the "Dilutive  Event") the Exercise Price
shall be reduced so that the Exercise Price in effect immediately  following the
Dilutive  Event will equal the  Dilutive  Price;  and in the event the  Dilutive
Event  shall  occur  at  any  time  on or  after  the  60th  day  following  the
consummation of a Qualified  Offering,  the Exercise Price shall be reduced to a
price  determined by  multiplying  the then  effective  Exercise Price in effect
immediately  following  the Dilutive  Event by a fraction of which the numerator
shall be the number of shares of Common Stock  outstanding  immediately prior to
the  Dilutive  Issuance  plus the  number of shares  of Common  Stock  which the
aggregate  offering price for such Dilutive  Issuance  (assuming  receipt by the
Company in full of all  consideration  payable  upon  exercise  of such  rights,
options or warrants) would purchase at the Exercise  Price,  and the denominator
of which  shall be the sum of the number of shares of Common  Stock  outstanding
immediately  prior to the Dilutive  Issuance plus the number of shares of Common
Stock so issued or issuable in connection with the Dilutive Issuance.  Upon each
adjustment  of the Exercise  Price  pursuant to the  provisions  of this Section
11(b),  the number of Warrant Shares  issuable upon the exercise of this Warrant
shall be adjusted to the nearest  full amount by  multiplying  a number equal to
the Exercise Price in effect  immediately prior to such adjustment by the number
of Warrant Shares  issuable upon exercise of the Warrants  immediately  prior to
such  adjustment  and dividing the product so obtained by the adjusted  Exercise
Price.

                  (c) As used herein:

                           "Additional  Shares of Common  Stock"  shall mean all
                           shares of Common  Stock issued or deemed to be issued
                           by the Company after the date hereof which  represent
                           a  Triggering  Issuance.  If the  Company  issues any
                           Options or  Convertible  Securities  (as  hereinafter
                           defined),  the  maximum  number  of  shares of Common
                           Stock  issuable  thereunder,  shall be  deemed  to be
                           Additional  Shares of Common  Stock  issued as of the
                           time of such issue, if the consideration per share of
                           such   Additional   Shares   of   Common   Stock  (as
                           hereinafter    determined)    is   less    than   the
                           then-applicable  Exercise  Price,  until such time as
                           such   Options  or   Convertible   Securities   shall
                           terminate or be  exercised  or converted  into Common
                           Stock, upon which time the number of shares of Common
                           Stock actually thereupon issued shall be deemed to be
                           Additional  Shares of Common Stock. The Company shall
                           be deemed to have issued the maximum number of shares
                           of Common Stock potentially underlying any Options or
                           Convertible    Securities.     Notwithstanding    the
                           foregoing,  no issuance or deemed issuance nor Common
                           Stock or options or warrants to purchase Common Stock
                           issued to (i) officers,  directors or employees of or

                                      -6-
<PAGE>

                           consultants   to   the   Company   pursuant   to  any
                           compensation  agreement,  plan or  arrangement or the
                           issuance  of Common  Stock upon the  exercise  of any
                           such options or warrants,  provided  such  securities
                           were issued prior to the date hereof or pursuant to a
                           stock  option plan that was  approved by the board of
                           directors  and  stockholders  of the  Company or were
                           assumed in a merger or other business  combination by
                           the  Company   (ii)  upon   conversion   of  existing
                           convertible  securities  outstanding  as of the  date
                           hereof;  (iii) upon exercise of outstanding  warrants
                           existing as of the date hereof or this  Warrant;  and
                           (iv) in connection with a business  acquisition where
                           the   stockholders  of  the  Company  prior  to  such
                           acquisition  own 50% or more of the  Common  Stock of
                           the  Company  following  such  acquisition,  or to an
                           institution or bank lender or licensor of tangible or
                           intangible   property  in  connection   with  a  loan
                           transaction   or   equipment   lease   or   licensing
                           transaction (provided that the primary purpose of any
                           such equipment lease or licensing  transaction is not
                           raising  capital),  shall be deemed the  issuance  of
                           Additional Shares of Common Stock.

                           "Options"  shall mean rights,  options or warrants to
                           subscribe for,  purchase or otherwise  acquire either
                           Common Stock or Convertible Securities.

                           "Convertible  Securities" shall mean any evidences of
                           indebtedness,  shares  (other than  Common  Stock) or
                           other securities  directly or indirectly  convertible
                           into or exchangeable for Common Stock.

         With respect to Options and Convertible Securities, "consideration" per
share of Additional Shares of Common Stock shall be determined by adding (x) the
aggregate  consideration  received upon  issuance of the Options or  Convertible
Securities  divided  by the number of shares  receivable  upon the  exercise  or
conversion thereof and (y) the minimum possible consideration per share received
or to be received per share upon the  exercise,  conversion  or exchange of such
Options or  Convertible  Securities  for shares of Common  Stock.  Common  Stock
outstanding  as of a given date  shall be the  number of shares of Common  Stock
(excluding treasury shares, if any) issued and outstanding.

                  (d) In  addition to the above  adjustments,  in the event that
there is an Event of Default (as defined in the  Debentures)  as a result of the
failure to pay amounts due under the Debenture for more than five (5) days after
such payment is due, the then effective  Exercise Price shall be reduced by 1.5%
per month of the Exercise Price in effect upon such Event of Default, until such
default is cured,  up to a maximum  reduction  of 20% of the  Exercise  Price in
effect upon such Event of Default.

         12.   Reorganization,   Reclassification,   Merger,   Consolidation  or
Disposition  of  Assets.  In case the  Company  shall  reorganize  its  capital,
reclassify  its  capital  stock,  consolidate  or  merge  with or  into  another
corporation  (where the Company is not the surviving  corporation or where there

                                      -7-
<PAGE>

is a change in or distribution with respect to the Common Stock of the Company),
or sell, transfer or otherwise dispose of all or substantially all its property,
assets or business  to another  corporation  and,  pursuant to the terms of such
reorganization,   reclassification,  merger,  consolidation  or  disposition  of
assets, shares of common stock of the successor or acquiring corporation, or any
cash,  shares of stock or other securities or property of any nature  whatsoever
(including  warrants or other subscription or purchase rights) in addition to or
in lieu of  common  stock of the  successor  or  acquiring  corporation  ("Other
Property"),  are to be received by or distributed to the holders of Common Stock
of the Company,  then the Holder shall have the right thereafter to receive,  at
the option of the Holder, upon exercise of this Warrant, the number of shares of
common stock of the successor or acquiring  corporation or of the Company, if it
is the surviving corporation,  and Other Property receivable upon or as a result
of such reorganization,  reclassification,  merger, consolidation or disposition
of  assets by a Holder of the  number of shares of Common  Stock for which  this
Warrant is  exercisable  immediately  prior to such  event.  In case of any such
reorganization,   reclassification,  merger,  consolidation  or  disposition  of
assets, the successor or acquiring corporation (if other than the Company) shall
expressly  assume the due and punctual  observance  and  performance of each and
every covenant and condition of this Warrant to be performed and observed by the
Company  and all the  obligations  and  liabilities  hereunder,  subject to such
modifications  as may be deemed  appropriate  (as  determined  in good  faith by
resolution  of the Board of  Directors  of the  Company) in order to provide for
adjustments of Warrant Shares for which this Warrant is exercisable  which shall
be as nearly  equivalent as practicable to the adjustments  provided for in this
Section 12. For purposes of this Section 12,  "common  stock of the successor or
acquiring  corporation"  shall  include stock of such  corporation  of any class
which is not  preferred  as to dividends or assets over any other class of stock
of such  corporation  and which is not  subject  to  redemption  and shall  also
include any evidences of indebtedness, shares of stock or other securities which
are convertible into or exchangeable for any such stock,  either  immediately or
upon the arrival of a specified  date or the happening of a specified  event and
any warrants or other rights to  subscribe  for or purchase any such stock.  The
foregoing  provisions  of this Section 12 shall  similarly  apply to  successive
reorganizations,  reclassifications,  mergers,  consolidations or disposition of
assets.

         13.  Voluntary  Adjustment by the Company.  The Company may at any time
during the term of this Warrant  reduce the then current  Exercise  Price to any
amount and for any period of time deemed  appropriate  by the Board of Directors
of the Company.

         14.  Notice of  Adjustment.  Whenever  the number of Warrant  Shares or
number or kind of securities or other property  purchasable upon the exercise of
this Warrant or the Exercise Price is adjusted, as herein provided,  the Company
shall give notice thereof to the Holder,  which notice shall state the number of
Warrant Shares (and other securities or property)  purchasable upon the exercise
of this  Warrant  and the  Exercise  Price of such  Warrant  Shares  (and  other
securities or property) after such  adjustment,  setting forth a brief statement
of the facts  requiring  such  adjustment  and setting forth the  computation by
which such adjustment was made.

         15. Notice of Corporate Action. If at any time:

                           (a) the Company shall take a record of the holders of
         its  Common  Stock  for the  purpose  of  entitling  them to  receive a
         dividend  or  other  distribution,  or any  right to  subscribe  for or
         purchase any evidences of its indebtedness,  any shares of stock of any
         class or any other  securities  or  property,  or to receive  any other
         right, or

                                      -8-
<PAGE>

                           (b) there shall be any capital  reorganization of the
         Company,  any reclassification or recapitalization of the capital stock
         of the Company or any  consolidation  or merger of the Company with, or
         any sale, transfer or other disposition of all or substantially all the
         property, assets or business of the Company to, another corporation or,

                           (c)  there  shall  be  a  voluntary  or   involuntary
         dissolution, liquidation or winding up of the Company;

then,  in any one or more of such  cases (but not in such cases if the rights of
the Holder or holders of Common Stock will not be materially  affected  thereby,
as for  example  in the case of a merger to effect a change  of  domicile),  the
Company shall give to Holder (i) at least 20 days' prior  written  notice of the
date on which a record date shall be selected for such dividend, distribution or
right or for determining  rights to vote in respect of any such  reorganization,
reclassification,    merger,   consolidation,   sale,   transfer,   disposition,
liquidation  or  winding  up,  and (ii) in the case of any such  reorganization,
reclassification,    merger,   consolidation,   sale,   transfer,   disposition,
dissolution,  liquidation  or winding up, at least 20 days' prior written notice
of the date when the same shall take place.  Such notice in accordance  with the
foregoing  clause also shall specify (i) the date on which any such record is to
be taken for the purpose of such dividend,  distribution  or right,  the date on
which the  holders  of Common  Stock  shall be  entitled  to any such  dividend,
distribution or right, and the amount and character  thereof,  and (ii) the date
on which any such reorganization, reclassification, merger, consolidation, sale,
transfer, disposition,  dissolution,  liquidation or winding up is to take place
and the time, if any such time is to be fixed, as of which the holders of Common
Stock shall be entitled to exchange their Warrant Shares for securities or other
property deliverable upon such disposition,  dissolution, liquidation or winding
up. Each such written notice shall be sufficiently  given if addressed to Holder
at the  last  address  of  Holder  appearing  on the  books of the  Company  and
delivered in accordance with Section 17(d).

         16. Authorized Shares. The Company covenants that during the period the
Warrant is outstanding,  it will reserve from its authorized and unissued Common
Stock a  sufficient  number of shares to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant.  The Company
further  covenants  that its  issuance of this  Warrant  shall  constitute  full
authority  to its  officers  who are charged  with the duty of  executing  stock
certificates  to execute and issue the  necessary  certificates  for the Warrant
Shares upon the exercise of the purchase rights under this Warrant.  The Company
will take all such  reasonable  action as may be  necessary  to assure that such
Warrant  Shares  may be issued  as  provided  herein  without  violation  of any
applicable law or regulation,  or of any requirements of the trading market upon
which the Common Stock may be listed.

                  Except  and to the  extent as waived  or  consented  to by the
Holder,  the Company  shall not by any action,  including,  without  limitation,
amending  its  certificate  of  incorporation  or  through  any  reorganization,
transfer  of  assets,  consolidation,  merger,  dissolution,  issue  or  sale of
securities or any other voluntary action,  avoid or seek to avoid the observance
or  performance  of any of the terms of this  Warrant,  but will at all times in
good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or  appropriate to protect the rights of Holder

                                      -9-
<PAGE>

as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (a) not increase the par value of any Warrant
Shares above the amount payable therefor upon such exercise immediately prior to
such  increase  in par value,  (b) take all such action as may be  necessary  or
appropriate  in order that the Company may validly and legally  issue fully paid
and nonassessable  Warrant Shares upon the exercise of this Warrant, and (c) use
commercially reasonable efforts to obtain all such authorizations, exemptions or
consents from any public regulatory body having  jurisdiction  thereof as may be
necessary to enable the Company to perform its obligations under this Warrant.

                  Before  taking any action which would result in an  adjustment
in the number of Warrant  Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such  authorizations  or exemptions
thereof,  or consents  thereto,  as may be necessary from any public  regulatory
body or bodies having jurisdiction thereof.

         17. Miscellaneous.

                  (a)  Jurisdiction.  This Warrant  shall  constitute a contract
         under the laws of New York,  without  regard to its  conflicts  of laws
         principles or rules.

                  (b)  Restrictions.  The Holder  acknowledges  that the Warrant
         Shares  acquired upon the exercise of this Warrant,  if not registered,
         will  have  restrictions  upon  resale  imposed  by state  and  federal
         securities laws.

                  (c) Nonwaiver and Expenses.  No course of dealing or any delay
         or failure to exercise any right  hereunder on the part of Holder shall
         operate  as a waiver  of such  right or  otherwise  prejudice  Holder's
         rights,  powers  or  remedies,  notwithstanding  all  rights  hereunder
         terminate  on the  Termination  Date.  If  the  Company  willfully  and
         knowingly  fails to comply with any  provision of this  Warrant,  which
         results in any material damages to the Holder, the Company shall pay to
         Holder  such  amounts  as shall be  sufficient  to cover  any costs and
         expenses  including,  but not limited to,  reasonable  attorneys' fees,
         including  those  of  appellate  proceedings,  incurred  by  Holder  in
         collecting  any amounts due pursuant  hereto or in otherwise  enforcing
         any of its rights, powers or remedies hereunder.

                  (d) Notices. Any notice, request or other document required or
         permitted to be given or  delivered to the Holder by the Company  shall
         be delivered in accordance  with the notice  provisions of the Purchase
         Agreement.

                  (e)  Limitation  of  Liability.  No provision  hereof,  in the
         absence of any affirmative action by Holder to exercise this Warrant or
         purchase  Warrant  Shares,  and no enumeration  herein of the rights or
         privileges  of Holder,  shall give rise to any  liability of Holder for
         the  purchase  price of any  Common  Stock or as a  stockholder  of the
         Company,  whether  such  liability  is  asserted  by the  Company or by
         creditors of the Company.

                  (f)  Remedies.  Holder,  in  addition  to  being  entitled  to
         exercise all rights granted by law, including recovery of damages, will
         be entitled to specific  performance  of its rights under this Warrant.
         The  Company  agrees  that  monetary  damages  would  not  be  adequate

                                      -10-
<PAGE>

         compensation  for any loss  incurred by reason of a breach by it of the
         provisions  of this  Warrant and hereby  agrees to waive the defense in
         any  action  for  specific  performance  that a remedy  at law would be
         adequate.

                  (g) Successors and Assigns.  Subject to applicable  securities
         laws,  this  Warrant and the rights and  obligations  evidenced  hereby
         shall inure to the benefit of and be binding upon the successors of the
         Company  and the  successors  and  permitted  assigns  of  Holder.  The
         provisions  of this  Warrant are  intended to be for the benefit of all
         Holders from time to time of this Warrant and shall be  enforceable  by
         any such Holder or holder of Warrant Shares.

                  (h) Amendment.  This Warrant may be modified or amended or the
         provisions hereof waived with the written consent of the Holder and the
         Company.

                  (i) Severability.  Wherever  possible,  each provision of this
         Warrant  shall be  interpreted  in such manner as to be  effective  and
         valid under  applicable law, but if any provision of this Warrant shall
         be prohibited by or invalid under  applicable law, such provision shall
         be ineffective to the extent of such prohibition or invalidity, without
         invalidating   the  remainder  of  such  provisions  or  the  remaining
         provisions of this Warrant.

                  (j)  Headings.  The headings  used in this Warrant are for the
         convenience of reference only and shall not, for any purpose, be deemed
         a part of this Warrant.

                              ********************

                                      -11-
<PAGE>

                  IN WITNESS WHEREOF,  the Company has caused this Warrant to be
executed by its officer thereunto duly authorized.

Dated:  March 2, 2005
                                            ROOMLINX, INC.

                                            By:
                                                -------------------------------
                                                Name:  Frank Elenio
                                                Title: Chief Financial Officer

                                      -12-
<PAGE>

                               NOTICE OF EXERCISE

To:      RoomLinX, Inc.

         (1)______The  undersigned  hereby elects to purchase  ________  Warrant
Shares of  RoomLinX,  Inc.  pursuant to the terms of the attached  Warrant,  and
tenders  herewith  payment  of the  exercise  price in full,  together  with all
applicable transfer taxes, if any.

         (2)______Payment shall take the form of (check applicable box):

                           [ ] in lawful money of the United States; or

                           [ ] the cancellation of such number of Warrant Shares
                           as is necessary,  in accordance  with the formula set
                           forth in  subsection  3(c),  to exercise this Warrant
                           with respect to the maximum  number of Warrant Shares
                           purchasable   pursuant  to  the   cashless   exercise
                           procedure set forth in subsection 3(c).

         (3)______Please  issue a certificate or certificates  representing said
Warrant  Shares  in the  name of the  undersigned  or in such  other  name as is
specified below:

                       Name:      ___________________________

                       Address:   ___________________________

                                  ___________________________

                       SS or Tax
                       ID number: ___________________________

The Warrant Shares shall be delivered to the following:

                                  ___________________________

                                  ___________________________

                                  ___________________________

                                        [Warrant holder]

                                        By:
                                            -----------------------------
                                              Name:
                                              Title:

                                        Dated:
                                               --------------------------

<PAGE>

                                 ASSIGNMENT FORM

                    (To assign the foregoing warrant, execute
                   this form and supply required information.
                 Do not use this form to exercise the warrant.)

         FOR VALUE  RECEIVED,  the  foregoing  Warrant and all rights  evidenced
thereby are hereby assigned to

________________________________________ whose address is

_____________________________________________________________________________ .

_____________________________________________________________________________

 _________                                   Dated:  ______________, _______

            Holder's Signature:   ___________________________

              Holder's Address:   ___________________________

                                  ___________________________

Signature Guaranteed:  ___________________________________________

NOTE: The signature to this  Assignment Form must correspond with the name as it
appears on the face of the Warrant,  without  alteration or  enlargement  or any
change whatsoever,  and must be guaranteed by a bank or trust company.  Officers
of corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing Warrant.SECURITIES PURCHASE AGREEMENT

      SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of March 2,
2005, among ROOMLINX, INC., a Nevada corporation (the "Company"), and the
investors signatory hereto.

                                    RECITALS:
                                    ---------

      In consideration of the mutual covenants and agreements set forth herein
and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, and intending to be legally bound hereby, the
parties agree as follows:

                                    ARTICLE I
                         PURCHASE AND SALE OF SECURITIES
                         -------------------------------

      Section 1.1 Purchase and Sale. The Company hereby agrees to issue and sell
to each signatory hereto (collectively, the "Investors", and each, individually,
an "Investor") and, subject to all of the terms and conditions hereof and in
reliance on the representations and warranties set forth or referred to herein,
each Investor severally agrees to purchase the principal amount of Convertible
Debentures set forth as "Amount of Investment" on the signature pages hereto,
such Convertible Debentures to be in the form attached hereto as Exhibit A (the
"Debentures") and a warrant (the "Warrant") to purchase up to a number of shares
of Common Stock, par value $.001 per share of the Company (the "Common Stock"),
equal to 65% of the original principal amount of such Investor's Debenture
divided by $0.075, and in the form attached hereto as Exhibit B. The Debentures
and the Warrants shall be collectively referred to herein as the "Securities."
The aggregate principal amount of Debentures to be issued and sold hereunder
shall be up to $1,100,000. Each Investor encloses herewith a check payable to,
or will immediately make a wire transfer payment to "Signature Bank as Escrow
Agent for RoomLinX, Inc." in the full amount of the purchase price of the
Debentures and Warrants being purchased. Such funds will be held for the
Investor's benefit, and will be returned promptly, without interest, penalty,
expense or deduction if the Company does not accept such Investor's
subscription. Together with the check for, or wire transfer of, the full
purchase price, each Investor is delivering a completed and executed signature
page of this Agreement.

      Section 1.2 Closing. Upon satisfaction of the conditions to closing set
forth herein the closing of the purchase and sale of the Debentures and Warrants
(the "Closing") shall occur at the offices of counsel to the Placement Agent (as
hereinafter defined), or such other location as the parties shall mutually
agree. The date of the Closing shall be referred to herein as the "Closing
Date."

                                   ARTICLE II
                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY
                  ---------------------------------------------

      The Company represents and warrants to the Investors as follows, which
representations and warranties are true as of the date hereof and as of the
Closing Date:

      Section 2.1 Corporate Organization. The Company and each of its
subsidiaries, if any, is a corporation duly incorporated, validly existing and
subsisting under the laws of the State of Nevada. The Company and each of its
subsidiaries have all requisite power and authority to own, operate and lease
its properties and to conduct its business as currently conducted. The Company
and each of its subsidiaries is duly qualified or licensed to do business and is
in good standing in each jurisdiction in which its ownership or leasing of
property or the conduct of its business requires such licensing or
qualification, except to the extent that the failure to be so qualified or
licensed would not have a Material Adverse Effect (as defined below). As used in
this Agreement, "Material Adverse Effect" means any event, circumstance or
development which individually or in the aggregate could reasonably be expected
to have a material adverse effect on the business, properties, operations,
condition (financial or otherwise), assets, liabilities, tradability of the
Common Stock, earnings or results of operations of the Company and its
subsidiaries or on the transactions contemplated hereby. If the Company does not
have any subsidiaries, references to "subsidiaries" in this Article II shall be
disregarded.

<PAGE>

      Section 2.2 Subsidiaries. The Company does not directly or indirectly own
any equity or similar interest, or any interest convertible into or exchangeable
or exercisable for any equity or similar interest, in any corporation,
partnership, limited liability company, joint venture or other business
association, entity or person.

      Section 2.3 Authorization. The Company has all requisite power and full
legal right to execute and deliver this Agreement and the Ancillary Agreements,
and to perform all of its obligations hereunder and thereunder in accordance
with the respective terms hereof and thereof. This Agreement and the Ancillary
Agreements and the transactions contemplated hereby and thereby have been duly
approved and authorized by all requisite corporate action on the part of the
Company, and this Agreement has been duly executed and delivered by the Company
and constitutes, and each of the Ancillary Agreements, when executed and
delivered by the Company at the Closing, will constitute, a legal, valid, and
binding obligation of the Company, enforceable against it in accordance with its
respective terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to the enforcement of creditors' rights and remedies or by other
equitable principles of general application. The execution, delivery, and
performance by the Company of this Agreement and the Ancillary Agreements in
accordance with their respective terms, and the consummation by the Company of
the transactions contemplated hereby or thereby, will not result (with or
without the giving of notice or the lapse of time or both) in any conflict,
violation, breach, or default, or the creation of any Lien, or the termination,
acceleration, vesting, or modification of any right or obligation, under or in
respect of (x) the Certificate of Incorporation or By-laws of the Company and
its subsidiaries, (y) any judgment, decree, order, statute, rule or regulation
binding on or applicable to the Company or its subsidiaries, or (z) any
agreement or instrument to which the Company or any of its subsidiaries is a
party or by which it or any of its assets is or are bound, except, in the case
of clauses (y) and (z), for conflicts, violations, breaches, defaults, liens,
terminations, accelerations, vesting or modifications which would not have a
Material Adverse Effect.

      Section 2.4 Capitalization. (a) Immediately prior to the Closing, not
giving effect to the sale and purchase of the Securities, the authorized and the
outstanding capital stock of the Company (on a Fully Diluted Basis including all
Derivative Securities) will be as set forth in Schedule 2.4. All such
outstanding shares of capital stock will be duly authorized, validly issued,
fully paid, and nonassessable, and will have been issued free and clear of
Liens. Except as set forth in Schedule 2.4, no adjustment will be required to be
made as a result of the Company's issuance of the Securities to the rate at
which any shares of any class of the equity securities of the Company,
subscriptions, options, warrants, calls, commitments or agreements or Derivative
Securities of the Company are convertible into or exercisable for shares of
Common Stock, Derivative Securities or shares of other equity securities of the
Company (by reason of any "anti-dilution" provisions or agreements or
otherwise).

      (b) Except as set forth on Schedule 2.4, the Company does not have, is not
bound by, and has no obligation to grant or enter into, any outstanding
subscriptions, options, warrants, calls, commitments, or agreements of any
character calling for it to issue, deliver, or sell, or cause to be issued,
delivered, or sold, any shares of its capital stock, any other equity security,
or any securities convertible into, exchangeable for, or representing the right
to subscribe for, purchase, or otherwise acquire any shares of its capital stock
or any other equity security.

                                       2
<PAGE>

      (c) Except as set forth in Schedule 2.4, the Company (i) has no
outstanding obligations, contractual or otherwise, to repurchase, redeem, or
otherwise acquire any shares of capital stock or other equity securities of the
Company, (ii) is not a party to or bound by any agreement or instrument relating
to the voting of any of its securities, and (iii) is not a party to or bound by
any agreement or instrument under which any person has the right to require it
to effect, or to include any securities held by such person in, any registration
under the Securities Act (as defined in Section 2.5).

      (d) All of the Securities have been offered and at the Closings will be
issued and sold, in compliance with (i) all applicable preemptive or similar
rights of all persons, and (ii) assuming the truthfulness and accuracy of the
representations made by the Investors in Section 3 hereof, all applicable
provisions of the Securities Act and the rules and regulations thereunder, and
all applicable state securities laws and the rules and regulations thereunder
and other applicable securities laws and regulations.

      (e) The Securities (which, for purposes of this Section 2.4(e) shall be
deemed to include all shares of Common Stock issuable upon conversion of the
Debentures and all shares of Common Stock issuable upon exercise of the
Warrants) shall, upon issuance pursuant to the terms hereof and/or the terms of
the Debentures, as the case may be, be duly authorized and validly issued, fully
paid and non-assessable and free and clear of any Lien, security interest,
option or other charge or encumbrance and free of all preemptive and other third
party rights.

      Section 2.5 Financial Statements/SEC Reports. The Company has filed all
reports required to be filed by it under the Exchange Act, including pursuant to
Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or
such shorter period as the Company was required by law to file such material)
(the foregoing materials being collectively referred to herein as the "SEC
Reports") on a timely basis or has received a valid extension of such time of
filing and has filed any such SEC Reports prior to the expiration of any such
extension). The SEC Reports comply in all material respects with the
requirements of the Securities Act of 1933, as amended (the "Securities Act"),
or the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as the
case may be, and rules and regulations of the SEC promulgated thereunder. The
Company has identified and made available to the Investors a copy of all SEC
Reports filed within the 10 days preceding the date hereof. As of their
respective dates, the SEC Reports filed on or after June 28, 2004 complied in
all material respects with the requirements of the Securities Act and the
Exchange Act and the rules and regulations of the Commission promulgated
thereunder, and none of the SEC Reports, when filed, contained any untrue
statement of a material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. The financial
statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations
of the SEC with respect thereto as in effect at the time of filing. Such
financial statements have been prepared in accordance with GAAP, except as may
be otherwise specified in such financial statements or the notes thereto, and
fairly present in all material respects the financial position of the Company
and its consolidated subsidiaries as of and for the dates thereof and the
results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.

      Section 2.6 No Undisclosed or Contingent Liabilities. Except as set forth
in Schedule 2.6, neither the Company nor its subsidiaries has any liabilities or
obligations of any nature (whether absolute, accrued, contingent or otherwise
and whether due or to become due) which are not fully reflected or reserved
against on the balance sheet as of September 30, 2004 (including the footnotes
and schedules thereto, the "Balance Sheet") in accordance with GAAP, except for
(i) liabilities and obligations incurred in the ordinary course of business and
consistent with past practice since the date thereof and (ii) liabilities not
required to be so reflected or reserved against in accordance with GAAP.

                                       3
<PAGE>

      Section 2.7 Trading With the Enemy Act; Patriot Act. No sale of the
Company's securities nor the Company's use of the proceeds from such sale has
violated the Trading with the Enemy Act, as amended, or any of the foreign
assets control regulations of the United States Treasury Department (31 CFR,
Subtitle B, Chapter V, as amended) or any enabling legislation or executive
order relating thereto. Without limiting the foregoing, the Company (a) is not a
person whose property or interests in property are blocked pursuant to Section 1
of Executive Order 13224 of September 23, 2001 Blocking Property and Prohibiting
Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism
(66 Fed. Reg. 49079 (2001)) and (b) does not engage in any dealings or
transactions, or be otherwise associated, with any such person. The Company is
in compliance in all material respects with the USA Patriot Act of 2001 (signed
into law October 26, 2001).

      Section 2.8 Absence of Certain Changes. Except as set forth on Schedule
2.8 or otherwise disclosed in the SEC Reports, since the date of the Balance
Sheet, the Company has conducted its business only in the ordinary course and
consistent with past practice, and has not:

            (a) suffered any Material Adverse Effect;

            (b) materially increased, or experienced any change in any
      assumptions underlying or methods of calculating, any bad debt,
      contingency or other reserves;

            (c) paid, discharged or satisfied any claims, liabilities or
      obligations (absolute, accrued, contingent or otherwise) other than the
      payment, discharge or satisfaction in the ordinary course of business and
      consistent with past practice of liabilities and obligations reflected or
      reserved against in the Balance Sheet or incurred in the ordinary course
      of business and consistent with past practice since the date of the
      Balance Sheet;

            (d) permitted or allowed any of its assets to be subjected to any
      Lien of any kind;

            (e) incurred any indebtedness not in the ordinary course of business
      or executed any guarantees on behalf of any person;

            (f) canceled any material debts or waived any claims or rights of
      substantial value;

            (g) sold, transferred or otherwise disposed of any of its properties
      or assets, except in the ordinary course of business and consistent with
      past practice;

            (h) granted any general increase in the compensation of employees
      (including any such increase pursuant to any bonus, pension, profit
      sharing or other plan or commitment), other than such increases as are
      consistent with the Company's past practice or required by agreement or
      understanding disclosed to the Investors; or experienced any material loss
      of personnel of the Company, material change in the terms and conditions
      of the employment of the Company's key personnel, loss of any of the five
      most highly compensated employees of the Company or entered into any
      written employment agreement with any Company employee;

            (i) made any capital expenditure or commitment for additions to its
      property, equipment or intangible capital assets other than in the
      ordinary course of business and consistent with past practice;

            (j) made any change in any method of accounting or accounting
      practice, changed accountants or auditors or failed to maintain its books,
      accounts and records in the ordinary course of business and consistent
      with past practice;

                                       4
<PAGE>

            (k) failed to maintain any material properties or equipment in good
      operating condition and repair, ordinary wear and tear excepted;

            (l) entered into any transaction or made or entered into any
      material contract or commitment, except in the ordinary course of business
      and consistent with past practice, or terminated or amended any material
      contract or commitment;

            (m) declared, paid or set aside for payment any dividend or other
      distribution in respect of its capital stock or redeemed, purchased or
      otherwise acquired, directly or indirectly, any shares of its capital
      stock or other securities;

            (n) amended its Certificate of Incorporation or By-laws;

            (o) taken, suffered, or permitted any action which would render
      untrue any of the representations or warranties of the Company herein
      contained, and not omitted to take any action, the omission of which would
      render untrue any such representation or warranty; or

            (p) agreed in writing or otherwise committed to take actions in
      furtherance of, or otherwise taken, any action with respect to any of the
      matters described in this Section 2.8.

      Section 2.9 No Violation. Neither the execution and delivery of this
Agreement or any of the Ancillary Agreements by the Company nor the performance
by the Company of its obligations hereunder or thereunder will violate any
provision (including those requiring the furnishing of notice prior to the
taking of specific actions) of the rules of any marketplace on which the Common
Stock of the Company is listed or quoted.

      Section 2.10 Compliance with Applicable Law. The Company and each of its
subsidiaries is currently in compliance in all material respects with all
applicable laws (whether statutory or otherwise), rules, regulations, orders,
ordinances, judgments, decrees, writs, requirements and injunctions of all
governmental authorities, agencies, courts, and administrative tribunals, except
for such noncompliance that, individually and in the aggregate, would not have a
Material Adverse Effect. Neither the Company nor any of its subsidiaries has
received any notice or request for information from any federal, state, or local
governmental authority (i) that the Company (or any of its subsidiaries) has
been identified by the Environmental Protection Agency or any state
environmental regulatory authority as a potentially responsible party under
CERCLA with respect to a site listed on the National Priorities List, 40 C.F.R.
Part 300 Appendix B, or under any equivalent state law; or (ii) that it or any
of its subsidiaries is or may be in violation of any Environmental Laws or is or
will or may be a named party to any claim, action, cause of action, complaint or
legal or administrative proceeding arising out of any third party's incurrence
of Damages in connection with any environmental matters.

      Section 2.11 Licenses and Permits. The Company and its subsidiaries have
and maintain all licenses, permits and other authorizations from all
governmental authorities as are necessary for the conduct of their business as
presently conducted or in connection with the ownership or use of its
properties, except for licenses, permits and other authorizations that the
failure to obtain or maintain in effect, either singly or in the aggregate, has
not had and could not reasonably be expected to have a Material Adverse Effect.

                                       5
<PAGE>

      Section 2.12 Governmental Consents. Except for the filing of any forms
required under the federal securities laws (including any registration statement
under the Securities Act by the Company under the Registration Rights Agreement)
and any filings required under state "blue sky" laws, no consent, approval or
authorization of, or declaration, filing or registration with, any governmental
or regulatory authority is required to be made or obtained by the Company in
connection with the execution and delivery of this Agreement or any of the
Ancillary Agreements by the Company or the performance by the Company of its
obligations hereunder and thereunder, or the continued conduct by the Company of
its present business after the Closing.

      Section 2.13 Taxes. Except as set forth in Schedule 2.13, (i) the Company
and each of its subsidiaries have filed all Tax (as hereinafter defined) reports
and returns that they were required to file. All such reports and returns were
correct and complete in all material respects, (ii) all Taxes owed by the
Company or its subsidiaries (whether or not shown on any report or return) have
been paid or, if not yet due, appropriate accruals therefor as required under
GAAP have been made on the Company's financial records and on the financial
statements described in Section 2.5, (iii) since January 1, 2000, no claim has
been made by a taxing authority in a jurisdiction where the Company or any
subsidiaries does not pay Tax or file tax returns that the Company or any
subsidiary is or may be subject to Taxes assessed by such jurisdiction, (iv)
there are no Liens for Taxes (other than current Taxes not yet due and payable)
on the assets of the Company or any subsidiary, (v) there is no action, suit,
investigation, liability, taxing authority proceeding, or audit with respect to
any Tax now in progress, pending or, to the Company's knowledge, threatened,
against or with respect to the Company or any subsidiary, whether in respect of
any Tax reports and returns that were not filed in a timely manner or for any
other reason, (vi) no deficiency or proposed adjustment in respect of Taxes that
has not been settled or otherwise resolved has been asserted or assessed by any
taxing authority against the Company or any subsidiary which is not accrued on
the Balance Sheet and (vii) neither the Company nor any of its subsidiaries has
consented to extend the time in which any Tax may be assessed or collected by
any taxing authority. As used in this Section 2.13, the terms "Taxes" and "Tax"
mean all federal, state, local and foreign taxes, including, without limitation,
income, unemployment, withholding, payroll, social security, real property,
personal property, excise, sales, use and franchise taxes, levies, assessments,
duties, licenses and registration fees and charges of any nature whatsoever,
including interest, penalties and additions with respect thereto and any
interest in respect of such additions and penalties.

      Section 2.14 Litigation. Except as set forth in Schedule 2.14, there is no
action, suit or proceeding pending or, to the knowledge of the Company,
threatened against the Company or any of its subsidiaries, before any court or
arbitrator or any governmental body, agency or official in which there is a
reasonable likelihood of a decision which could have a Material Adverse Effect.

      Section 2.15 Title to Properties. Neither the Company nor any of its
subsidiaries owns any real property. Except as set forth on Schedule 2.15, the
Company has title to all of its properties and assets free and clear of all
Liens, charges and encumbrances, except Liens for taxes not yet due and payable
and such Liens or other imperfections of title, if any, that do not materially
detract from the value of or interfere with the present use of the property
affected thereby. There is no existing default or event of default (or event
which with notice or lapse of time, or both, would constitute a default) by the
Company or any subsidiary under any lease pursuant to which the Company or any
subsidiary leases real or personal property.

      Section 2.16 Contracts and Commitments. Except as set forth in Schedule
2.16, neither the Company nor any subsidiary is a party or subject to or bound
by (whether written or oral), nor has the Company or any subsidiary committed to
enter into in the future:

                                       6
<PAGE>

            (a) any agreement, which, in the future, would lead to (i) an
      acquisition, merger or similar transaction with respect to the Company, or
      (ii) a debt or equity financing for the Company (other than this Agreement
      and the Ancillary Agreements);

            (b) any agreement requiring it to purchase all or substantially all
      of its requirements for a particular product or service from a particular
      supplier or suppliers, or requiring it to supply all of a particular
      customer's or customers' requirements for a certain service or product;

            (c) any agreement with any current or former Affiliate, officer or
      director of the Company, or with any person in which any such Affiliate
      has an interest; and

            (d) any agreement with any domestic or foreign government or agency
      or executive office thereof or any subcontract between it and any third
      party relating to a contract between such third party and any domestic or
      foreign government or agency or executive office thereof.

      Section 2.17 Intellectual Property. (a) Except as set forth on Schedule
2.17, all patents, patent applications, trademarks, trade names, service marks,
logos and copyrights and other intellectual property used in or material to the
Company's and its subsidiaries' business as now being conducted or as proposed
to be conducted (collectively, and together with any technology, know-how, trade
secrets, processes, formulas, and techniques used in or material to the
Company's business, "Proprietary Information") are either owned or licensed by
the Company or its subsidiaries.

            (b) Except as set forth on Schedule 2.17, to the Company's
      knowledge, none of the Proprietary Information is being infringed by
      others, or is subject to any outstanding order, decree, judgment, or
      stipulation. No litigation (or other proceedings in or before any court or
      other governmental, adjudicatory, arbitral, or administrative body)
      relating to the Proprietary Information is pending or, to the Company's
      knowledge, threatened.

            (c) Except as set forth on Schedule 2.17, to the Company's
      knowledge, it is not infringing on or making unlawful use of any
      intellectual property or any proprietary or confidential information of
      any Person. No litigation (or other proceedings in or before any court or
      other governmental, adjudicatory, arbitral, or administrative body)
      charging the Company with infringement or unlawful use of any patent,
      trademark, copyright, or other proprietary right is pending or, to the
      Company's knowledge, threatened.

      Section 2.18 Insurance. Except as set forth on Schedule 2.18, the Company
and its subsidiaries maintain policies of insurance with, to the knowledge of
the Company, financially sound and reputable insurance companies, funds, or
underwriters, which are of the kinds and which cover such risks, and are in such
amounts and with such deductibles and exclusions, as are consistent with prudent
business practice for similarly situated businesses in the Company's business.
Except as set forth on Schedule 2.18, all such policies are in full force and
effect, are sufficient for compliance in all respects by the Company with all
requirements of law and of all agreements to which it is a party and will not
terminate or lapse or otherwise be affected in any way by reason of the
transactions contemplated hereby.

      Section 2.19 Investment Company. The Company is not an "investment
company" as such term is defined in the Investment Company Act of 1940, as
amended, and will not be an investment company under such Act upon consummation
of the transactions contemplated hereby or after giving effect to the use of
proceeds from the purchase of the Securities.

                                       7
<PAGE>

      Section 2.20 Securities Laws. The offer, sale and issuance of the
Securities without registration (assuming the accuracy of the representations
and warranties made by the Investors in Section 3.1 hereof) will not violate the
Securities Act, or any applicable state securities or "blue sky" laws or other
applicable laws. None of the Company, its affiliates or any person acting on its
behalf has engaged in any form of general solicitation or advertising (as
defined in Rule 502(c) of the Securities Act) or engaged in any action that
would require the registration under the Securities Act of the offering and sale
of the Securities pursuant to this Agreement.

      Section 2.21 Investment Banking; Brokerage. Except as set forth on
Schedule 2.21, there are no claims for investment banking fees, brokerage
commissions, finder's fees or similar compensation (exclusive of professional
fees to attorneys and accountants) in connection with the transactions
contemplated by this Agreement based on any arrangement or agreement made by or
on behalf of the Company or any of its Affiliates other than by the Placement
Agent.

      Section 2.22 Labor Relations. There is no charge pending or, to the
Company's knowledge, threatened, against or with respect to the Company or any
subsidiary before any court or agency and alleging unlawful discrimination in
employment practices, and there is no charge of or proceeding with regard to any
unfair labor practice against the Company or any subsidiary pending before the
National Labor Relations Board. There is no labor strike, dispute, slow-down, or
work stoppage pending or, to the Company's knowledge, threatened against or
involving the Company or any subsidiary. None of the employees of the Company or
any subsidiary is covered by any collective bargaining agreement, and no such
collective bargaining agreement is currently being negotiated. No one has
petitioned and, to the Company's knowledge, no one is now petitioning, for union
representation of any employees of the Company or any subsidiary. The Company
believes its relationships with its employees is satisfactory.

      Section 2.23 Disclosure. The Company confirms that neither it nor, to its
knowledge, any other person acting on its behalf has provided any of the
Investors or their agents or counsel with any information that constitutes or
might constitute material, nonpublic information. The Company understands and
confirms that the Investors may rely on the foregoing representations in
effecting transactions in securities of the Company. All disclosure provided to
the Investors regarding the Company, its business and the transactions
contemplated hereby, including the schedules to this Agreement, furnished by or
on behalf of the Company with respect to the representations and warranties made
herein do not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in
light of the circumstances under which they were made, not misleading. The
Company acknowledges and agrees that no Investor makes or has made any
representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in Section 3.

      Section 2.24 Sarbanes-Oxley; Internal Accounting Controls. The Company is
in material compliance with all provisions of the Sarbanes-Oxley Act of 2002
which are applicable to it as of the Closing Date. The Company and it
subsidiaries maintain a system of internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are executed in accordance
with management's general or specific authorizations, (ii) transactions are
recorded as necessary to permit preparation of financial statements in
conformity with GAAP and to maintain asset accountability, (iii) access to
assets is permitted only in accordance with management's general or specific
authorization, and (iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences. The Company has established disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
Company and designed such disclosure controls and procedures to ensure that
material information relating to the Company, including its subsidiaries, is
made known to the certifying officers by others within those entities,
particularly during the period in which the Company's most recently filed
periodic report under the Exchange Act, as the case may be, is being prepared.
The Company's certifying officers have evaluated the effectiveness of the
Company's controls and procedures as of a date prior to the filing date of the
most recently filed periodic report under the Exchange Act (such date, the
"Evaluation Date"). The Company presented in its most recently filed periodic
report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their
evaluations as of the Evaluation Date. Since the Evaluation Date, there have
been no significant changes in the Company's internal controls (as such term is
defined in Item 307(b) of Regulation S-K under the Exchange Act) or, to the
Company's knowledge, in other factors that could significantly affect the
Company's internal controls.

                                       8
<PAGE>

      Section 2.25 No Integrated Offering. Neither the Company, nor any of its
Affiliates, nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to
buy any security, under circumstances that would cause this offering of the
Securities to be integrated with prior offerings by the Company for purposes of
the Securities Act or which could violate any applicable shareholder approval
provisions.

                                   ARTICLE III
                 REPRESENTATIONS AND WARRANTIES OF THE INVESTORS
                 -----------------------------------------------

      Section 3.1 Representations and Warranties. Each Investor represents
severally as to himself only that (each of which representations and warranties
are true as of the date hereof and as of the Closing in which such Investor
participates):

            (a) He has all requisite power and full legal right to execute and
      deliver this Agreement and the Ancillary Agreements to which he is a party
      and to carry out his obligations hereunder and thereunder. The execution
      and delivery of this Agreement and the Ancillary Agreements, to which he
      is a party and the performance by him of his obligations hereunder and
      thereunder, have been duly authorized by him, and no other proceeding
      therefor on his part is required. This Agreement and each of the Ancillary
      Agreements to which he is a party have been duly executed and delivered by
      him and constitute his valid and binding obligations, enforceable against
      him in accordance with its terms, except as such enforceability may be
      limited by applicable bankruptcy, insolvency, reorganization, moratorium,
      liquidation or similar laws relating to the enforcement of creditors'
      rights and remedies or by other equitable principles of general
      application.

            (b) He is purchasing the securities hereunder for his own account
      for investment only and not with a present view to the distribution
      thereof.

            (c) He has such knowledge and experience in financial and business
      matters that he is capable of evaluating the merits and risks of the
      investment contemplated by this Agreement and making an informed
      investment decision with respect thereto.

            (d) He has had the opportunity to ask questions and receive answers
      concerning the terms and conditions of the offering of securities
      purchased hereunder, as well as the opportunity to obtain additional
      information necessary to verify the accuracy of information furnished in
      connection with such offering that the Company possesses or can acquire
      without unreasonable effort or expense.

            (e) He understands that the Debentures and Warrants have not been
      registered under the Securities Act or any state securities laws, and may
      not be transferred unless subsequently registered thereunder or pursuant
      to an exemption from registration, and that a legend indicating such
      restrictions will be placed on the certificates representing the Warrants
      and the Debentures and on any shares of Common Stock issued upon exercise
      or conversion thereof.

                                       9
<PAGE>

            (f) There are no claims for investment banking fees, brokerage
      commissions, finder's fees or similar compensation (other than
      professional fees to attorneys and accountants) in connection with the
      transactions contemplated by this Agreement or any of the Ancillary
      Agreements based on any arrangement or agreement made by or on behalf of
      him.

            (g) He has adequate means of providing for his current financial
      needs and foreseeable contingencies and has no need for liquidity of the
      investment in the Debentures and Warrants for an indefinite period of
      time.

            (h) He is aware that an investment in the Debentures and Warrants
      involves a number of very significant risks and has carefully read and
      considered the information set forth herein and in the Company's
      disclosure schedules annexed hereto.

            (i) He is an "accredited investor" as defined under Rule 501 of the
      Securities Act.

                                   ARTICLE IV
                   COVENANTS OF THE COMPANY AND THE INVESTORS
                   ------------------------------------------

      Section 4.1 Further Assurances. The Company and each Investor shall
execute and deliver, or cause to be executed and delivered each Ancillary
Agreement to be executed and delivered by it or him. The Company shall execute
and deliver, or cause to be executed and delivered, all such additional
instruments and other documents and shall take such further actions as the
Investors may reasonably require to effectuate, carry out and comply with all of
the terms of this Agreement, the Ancillary Agreements and the transactions
contemplated hereby and thereby.

      Section 4.2 Reservation of Shares; Compliance with Laws. The Company will
at all times reserve the appropriate number of shares of Common Stock solely for
the purpose of issuance upon exercise of the Warrants and conversion of the
Debentures. The Company will file within the required time periods all filings,
notices and other documents required by applicable federal and state securities
laws in connection with the transactions contemplated by this Agreement. The
Company will comply, and cause each of its subsidiaries to comply in all
material respects with all applicable laws, rules, regulations and orders, such
compliance to include, without limitation, paying before the same become
delinquent all taxes, assessments and governmental charges imposed upon it or
upon its property except to the extent contested in good faith.

      Section 4.3 Non-Public Information. The Company covenants and agrees that
neither it nor any other Person acting on its behalf will provide any Investor
or its agents or counsel with any information that the Company believes
constitutes material non-public information, unless prior thereto such Investor
shall have executed a written agreement regarding the confidentiality and use of
such information. The Company understands and confirms that each Investor shall
be relying on the foregoing covenant in effecting transactions in securities of
the Company.

      Section 4.4 Use of Proceeds. The Company shall use the net proceeds from
the sale of the Securities hereunder as set forth on Schedule 4.4 hereto and not
for the satisfaction of any portion of the Company's debt, to redeem any Company
equity or equity-equivalent securities or to settle any outstanding litigation.

      Section 4.5 Conversion and Exercise Procedures. The form of Notice of
Exercise included in the Warrants and the form of Notice of Conversion included
in the Debentures set forth the totality of the procedures required of the
Investors in order to exercise the Warrants or convert the Debentures. No
additional legal opinion or other information or instructions shall be required
of the Investors to exercise their Warrants or convert their Debentures. The
Company shall honor exercises of the Warrants and conversions of the Debentures
and shall deliver shares of Common Stock in accordance with the terms,
conditions and time periods set forth in the Ancillary Agreements.

                                       10
<PAGE>

      Section 4.6 Sales, Liens, Etc. So long as the Debentures remain
outstanding, except as or otherwise provided herein or to the extent
pre-existing the date hereof, the Company shall not (i) sell, assign (by
operation of law or otherwise) or otherwise dispose of, or create or suffer to
exist any Lien upon or with respect to, any of the Company's assets other than
in the ordinary course of business, or assign any right to receive income in
respect thereof or (ii) create or suffer to exist any Lien upon or with respect
to any of its properties, whether now owned or hereafter acquired if such Lien
is not discharged within thirty (30) days of its imposition, or assign any right
to receive income or to secure or provide for the payment of any debt of any
Person, without the prior written consent of the holders of at least 66.67%
principal amount of Debentures then outstanding.

      Section 4.7 Debt. So long as the Debentures remain outstanding, the
Company shall not create or suffer to exist any debt, other than (i) the debt
incurred pursuant to this Agreement, (ii) purchase money financing for
equipment, (iii) trade payables incurred in the ordinary course of business
consistent with past practice and (iv) debt which predates the date hereof and
is disclosed on Schedule 4.7 attached hereto.

      Section 4.8 Dividends, Etc. So long as the Debentures remain outstanding,
the Company shall not declare or make any dividend payment or other distribution
of assets, properties, cash, rights, obligations or securities on account of any
equity interest in the Company, or purchase, redeem or otherwise acquire for
value any equity interest in the Company or any rights or options to acquire any
such interests other than intra-company transactions and as may be required
pursuant to any Investor's exercise of the Debentures, or as may otherwise be
provided in this Agreement and/or the Ancillary Agreements.

      Section 4.9 Payment of Debentures. To the extent the Debentures have not
been paid in full or converted, the Company agrees to use the proceeds from all
future financing transactions to pay the then outstanding principal balance of
the Debentures plus accrued but unpaid interest thereon, until such Debentures
have been paid in full or have been converted. The Company also shall not
receive or accept any advance on that certain Standby Equity Agreement by and
between Cornell Capital Partners, LP and the Company, dated as of November 18,
2004, unless all proceeds from such advance are used to pay the then outstanding
principal balance of the Debentures, plus accrued but unpaid interest thereon,
until such Debentures have been paid in full or have been converted.

      Section 4.10 Consent. The Company shall not (i) issue in excess of 33% of
the voting securities of the Company, or (ii) merge into or consolidate with any
other entity (after which the stockholders of the Company immediately prior to
such transaction own less than 33% of the aggregate voting power of the Company
or the successor entity of such transaction), or (iii) sell or transfer its
assets, as an entirety or substantially as an entirety, to another entity (where
the stockholders of the Company immediately prior to such transaction own less
than 33% of the aggregate voting power of the acquiring entity immediately after
the transaction) ((i)-(iii) each, a "Transaction") without the prior written
consent of the holders of at least 66.67% of the principal amount of the
Debentures then outstanding, unless, as a condition to such Transaction, all
outstanding amounts on the Debentures are paid in full. The foregoing consent
shall not be required with respect to any Transaction consummated prior to May
31, 2005.

                                       11
<PAGE>

                                    ARTICLE V
                               CLOSING CONDITIONS
                               ------------------

      Section 5.1 Investor Closing Conditions. The obligation of the Investors
to consummate the transactions contemplated hereby is subject to satisfaction or
waiver of each of the following conditions at or prior to the Closing:

            (a) Secretary's Certificate. The Company shall have delivered to the
      Investors a certificate of the Secretary of the Company, dated as of the
      Closing Date, certifying: (i) the adoption by the Company's Board of
      Directors of attached resolutions authorizing, among other things, the
      execution and delivery of this Agreement and the Ancillary Agreements and
      the consummation of the transactions contemplated herein, and (ii) the
      incumbency and signatures of the officers of the Company executing this
      Agreement, the Ancillary Agreements and the other agreements and
      instruments contemplated herein.

            (b) Certificates. The Company shall have delivered to each Investor
      certificates evidencing the Debenture and Warrants acquired by such
      Investor pursuant to the terms hereof, each duly executed by the
      appropriate Company officers.

            (c) Opinion of Counsel. The Investors shall have received at the
      Closing from Lowenstein Sandler P.C., counsel to the Company, a favorable
      written opinion dated as of the Closing Date which shall be in the form
      attached hereto as Exhibit C hereto.

      Section 5.2 Mutual Closing Condition for the Closing. The obligation of
the Company and the Investors to consummate the transactions contemplated hereby
at the Closing is subject to the satisfaction or waiver of each of the following
condition at or prior to the Closing:

            (a) Injunctions. There not being in effect any order, decree or
      injunction of a court or agency of competent jurisdiction which enjoins or
      prohibits consummation of the transactions contemplated hereby.

            (b) Placement Agent Warrants. The Company shall have issued to the
      Placement Agent (as defined below) or its designees, warrants, in
      substantially the form of the Warrants, to purchase a number of shares of
      Common Stock equal to 15% of the number of shares of Common Stock
      underlying the Warrants issued hereunder, with a term of exercise of five
      years and including cashless exercise provisions.

                                   ARTICLE VI
                                   DEFINITIONS
                                   -----------

      Section 6.1 Certain Defined Terms. For purposes of this Agreement, the
following terms shall have the meanings set forth in this Section 6:

      "Affiliate" means any other person directly or indirectly controlling,
controlled by, or under direct or indirect common control with any referenced
person and includes without limitation, (a) any Person who is an officer,
director, or direct or indirect beneficial holder of at least 5% of the then
outstanding capital stock of any referenced Person, and any of the Family
Members of any such Person, (b) any Person of which a referenced Person and/or
its Affiliates (as defined in clause (a) above), directly or indirectly, either
beneficially own(s) at least 5% of the then outstanding equity securities or
constitute(s) at least a 5% equity participant, (c) in the case of a specified
Person who is an individual, Family Members of such Person, and (d) in the case
of the Investors, any entities for which an Investor or any of its Affiliates
serve as general partner and/or investment adviser or in a similar capacity, and
all mutual funds or other pooled investment vehicles or entities under the
control or management of such Investor or the general partner or investment
adviser thereof, or any Affiliate of any of them, or any Affiliates of any of
the foregoing.

                                       12
<PAGE>

      "Ancillary Agreements" means the Warrants, Debentures, the Registration
Rights Agreement and any other agreement or document delivered or executed in
connection with this Agreement or the transactions contemplated hereby.

      "CERCLA" means the Comprehensive Environmental Response, Compensation and
Liability Act of 1980, as amended.

      "Damages" means all damages, losses, claims, demands, actions, causes of
action, suits, litigations, arbitrations, liabilities, costs, and expenses,
including without limitation court costs and the fees and expenses of counsel
and experts.

      "Derivative Securities" means (i) all shares of stock and other securities
that are convertible into or exchangeable for shares of Common Stock, and (ii)
all options, warrants, and other rights to acquire shares of Common Stock or any
class of stock or other security or securities convertible into or exchangeable
for shares of Common Stock or any class of stock or other security.

      "Environmental Laws" means, collectively, the Resource Conservation and
Recovery Act, CERCLA, the Superfund Amendments and Reauthorization Act of 1986,
the Federal Clean Water Act, the Federal Clean Air Act, the Toxic Substances
Control Act, and any and all state or local statutes, regulations, ordinances,
orders, and decrees relating to health, safety, or the environment, each, as the
case may be, as amended.

      "Exchange Act" shall have the meaning set forth in Section 2.5.

      "Family Members" means, as applied to any individual, any parent, spouse,
child, spouse of a child, brother or sister of the individual, and each trust,
limited partnership or limited liability company created primarily for the
benefit of one or more of such persons and each custodian of a property of one
or more such persons and the personal representative or estate of any such
persons.

      "Fully Diluted Basis" means that the relevant calculation of the ownership
or percentage ownership (as applicable) of any Person of the equity securities
of the Company shall be performed as if (i) all Derivative Securities have been
exercised or converted, as the case may be, into shares of Common Stock of the
Company, and (ii) all shares of preferred stock or any other series of equity
securities of the Company shall have been converted into shares of Common Stock
of the Company.

      "GAAP" means generally accepted accounting principles in the United States
that are (i) consistent with the principles promulgated or adopted by the
Financial Accounting Standards Board and its predecessors, (ii) applied on a
basis consistent with prior periods, and (iii) such that, insofar as the use of
accounting principles is pertinent, a certified public accountant could deliver
an unqualified opinion with respect to financial statements in which such
principles have been properly applied.

                                       13
<PAGE>

      "Liens" means any and all liens, claims, mortgages, security interests,
charges, encumbrances, and restrictions on transfer of any kind, except: (i) in
the case of references to securities, any of the same arising under applicable
securities laws solely by reason of the fact that such securities were issued
pursuant to exemptions from registration under such securities laws, (ii) real
estate taxes not yet due and payable, and (iii) any lien in favor of any
landlord for unpaid rent, additional rent, or other charges, which lien is
created by statute or under any lease under which the Company or any of its
Subsidiaries is lessee, unless the Company is given written notice of the
imposition of any such lien described in this clause (iii).

      "Person" or "person" (regardless of whether capitalized) means any natural
person, entity, or association, including without limitation any corporation,
partnership, limited liability company, government (or agency or subdivision
thereof), trust, joint venture or proprietorship.

      "Registration Rights Agreement" means the Registration Rights Agreement
dated as of the Closing Date by and among the Company and the Investors
participating in such closing, in the form attached hereto as Exhibit D and
incorporated herein by reference.

      "SEC" means the Securities and Exchange Commission.

      "Subsidiary" or "Subsidiaries" means, with respect to any person, any
corporation a majority (by number of votes) of the outstanding shares of any
class or classes of which are at the time owned by such person or by a
Subsidiary of such person, if the holders of the shares of such class or classes
(a) are ordinarily, in the absence of contingencies, entitled to vote for the
election of a majority of the directors (or persons performing similar
functions) of the issuer thereof, even though the right so to vote has been
suspended by the happening of such a contingency, or (b) are at the time
entitled, as such holders, to vote for the election of a majority of the
directors (or persons performing similar functions) of the issuer thereof,
whether or not the right so to vote exists by reason of the happening of a
contingency.

                                   ARTICLE VII
                                  MISCELLANEOUS
                                  -------------

      Section 7.1 Independent Nature of Investors' Obligations and Rights. The
Company acknowledges each of the following: The obligations of each Investor
participating in this transaction are several and not joint with the obligations
of any other Investor, and no Investor shall be responsible in any way for the
performance of the obligations of any other Investor. Nothing contained herein
or in any other agreement, and no action taken by any Investor pursuant thereto,
shall be deemed to constitute the Investors as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Investors are in any way acting in concert or as a "group" (within the meaning
of Sections 13 and 16 of the Exchange Act and any rules promulgated thereunder),
in each case with respect to such obligations or the transactions contemplated
hereunder. Each Investor shall be entitled to independently protect and enforce
its rights, including without limitation the rights arising out of this
Agreement or out of the other agreements relating to this transaction, and it
shall not be necessary for any other Investor to be joined as an additional
party in any proceeding for such purpose. Each Investor has been represented by
its own separate legal counsel (or has chosen not to be represented by legal
counsel) in its review and negotiation of this agreement and the related
transaction documents. The Company has elected to provide various Investors with
the same terms and agreements for the convenience of the Company and not because
it was required or requested to do so by the Investors.

      Section 7.2 Waivers and Consents. For the purposes of this Agreement and
all agreements executed pursuant hereto, no course of dealing between the
Company and the Investors and no delay on the part of any party hereto in
exercising any rights hereunder or thereunder shall operate as a waiver of the
rights hereof or thereof. No provision hereof may be waived except by a written
instrument signed by the party so waiving such provision.

                                       14
<PAGE>

      Section 7.3 Governing Law; Jurisdiction; Venue etc. This Agreement shall
be governed by, and construed and enforced in accordance with, the laws of the
State of New York, without giving effect to the principles of conflicts of law
thereof. The state and federal courts of the State of New York located in New
York County shall have exclusive jurisdiction to hear and determine any claims
or disputes between the Investors and the other party or parties hereto
pertaining directly or indirectly to this Agreement and all documents,
instruments and agreements executed pursuant hereto, or to any matter arising
therefrom (unless otherwise expressly provided for therein); the exclusive
choice of forum set forth in this Section 7.3 shall not be deemed to preclude
the enforcement of any judgment obtained in such forum or the taking of any
action to enforce the same in any other appropriate jurisdiction. All of the
parties hereto waive all rights to trial by jury in any action or proceeding
instituted by any party against any other party arising out of, on or by reason
of this Agreement or the documents and transactions contemplated herein.

      Section 7.4 Headings. The descriptive headings in this Agreement have been
inserted for convenience only and shall not be deemed to limit or otherwise
affect the construction or interpretation of any provision thereof or hereof.

      Section 7.5 Counterparts. This Agreement may be executed simultaneously in
any number of counterparts, each of which when so executed and delivered shall
be taken to be an original; but such counterparts shall together constitute but
one and the same document.

      Section 7.6 Notices and Demands. Any notice or demand which is required or
provided to be given under this Agreement shall be deemed to have been
sufficiently given and received for all purposes when delivered by hand or by
telecopy that has been confirmed as received by 5:00 P.M. on a business day, one
(1) business day after being sent by nationally recognized overnight courier or
received by telecopy after 5:00 P.M. on any day, or five (5) business days after
being sent by certified or registered mail, postage and charges prepaid, return
receipt requested, to the following addresses:

      If to the Company:

              RoomLinX, Inc.
              401 Hackensack Ave., 3rd Floor
              Hackensack, NJ 07601
              Attn: Mr. Frank Elenio
              Facsimile: 201-525-1778

      With a copy to:

              Lowenstein Sandler, P.C.
              65 Livingston Avenue
              Roseland, NJ 07068
              Attn: Peter H. Ehrenberg, Esq.
              Facsimile: 973-597-2351

      If to the Investors:

              To their respective addresses set forth below their respective
              names on the signature pages hereto.

                                       15
<PAGE>

      Section 7.7 Severability. Whenever possible, each provision of this
Agreement shall be interpreted in such a manner as to be effective and valid
under applicable law, but if any provision of this Agreement shall be deemed
prohibited or invalid under such applicable law, such provision shall be
ineffective to the extent of such prohibition or invalidity, and such
prohibition or invalidity shall not invalidate the remainder of such provision
or the other provisions of this Agreement, provided, however, that no such
severability shall be effective if it materially changes the economic benefit of
this Agreement to any party.

      Section 7.8 Integration. This Agreement, including the exhibits, documents
and instruments referred to herein or therein, constitutes the entire agreement,
and supersedes any other prior agreements and understandings, both written and
oral, among the parties with respect to the subject matter hereof.

      Section 7.9 Publicity. The Company shall within four (4) business days
following the date hereof, issue a Current Report on Form 8-K disclosing the
material terms of the transactions contemplated hereby, and shall attach this
Agreement and each Ancillary Agreement required to be filed as an exhibit
thereto. The Company shall have the right to issue any press release or other
public statement in connection with the transaction contemplated hereby,
excluding the identity of the Investors, without the prior consent of the
Investors, but may disclose the identity of the Investors upon prior written
consent of the Investors, which shall not be unreasonably withheld.

      Section 7.10 Expenses. The Company and the Investors will each bear their
own costs and expenses and those of their respective advisors related to the
transactions herein contemplated, except that upon Closing the Company hereby
agrees to reimburse Casimir Capital, LP (the "Placement Agent") $15,000 for
their legal fees and related expenses. The Company shall pay all transfer agent
fees, stamp taxes and other taxes and duties levied in connection with the
issuance of any Securities.

      Section 7.11 Assignment. (a) The Company may not assign this Agreement or
its rights and obligations hereunder.

            (b) The rights and obligations hereunder and the Securities may be
      transferred by each of the Investors in its sole discretion at any time,
      in whole or in part, to any Person to whom such Investor transfers
      Securities.

            (c) Notwithstanding the other provisions of this Section 7.11, no
      Person acquiring any Common Stock in a public trade shall receive the
      benefit of any of the covenants set forth in this Agreement as an assignee
      thereof.

            (d) Subject to clause (c) immediately above, any Person acquiring,
      in a manner permitted by this Agreement, any Securities and/or rights of
      an Investor under this Agreement shall constitute an Investor for purposes
      of this Agreement and any reference to an Investor in this Agreement shall
      also refer to any such Person.

      Section 7.12 Equitable Relief. Each of the parties acknowledges that any
breach by such party of his obligations under this Agreement would cause
substantial and irreparable damage to one or more of the other parties and that
money damages would be an inadequate remedy therefor. Accordingly, each party
agrees that the other parties or any of them will be entitled to an injunction,
specific performance and/or other equitable relief to prevent the breach of such
obligations.

      Section 7.13 Usage. All pronouns and any variations thereof refer to the
masculine, feminine or neuter, singular or plural, as the context may require.
All terms defined in this Agreement in their singular or plural forms have
correlative meanings when used herein in their plural or singular forms,
respectively.

                                       16
<PAGE>

      Section 7.14 Facsimile Signatures. A facsimile signature on this Agreement
or an original signature delivered by facsimile shall be considered the same as
an original.

                  [Remainder of page intentionally left blank]

                                       17
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:/s/ Frank Elenio
                                           -----------------------------------
                                           Name:  Frank Elenio
                                           Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                           /s/ J. Edward Barth
                                           -----------------------------------
                                           Name: J Edward Barth

                            If an entity:

                                           Name of Entity:____________________

                                           By:________________________________
                                              Name:
                                              Title:

                            Amount of Investment: $25,000
                                                  ------------------------------

                            Number of Warrants  216,667
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       18
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By: /s/ Frank Elenio
                                            ------------------------------------
                                            Name:  Frank Elenio
                                            Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                            ____________________________________
                                            Name:

                            If an entity:

                                  Name of Entity: Heller Family Investments, LLC
                                                  ------------------------------

                                  By: /s/ Authorized Signatory
                                      ------------------------------------------
                                      Name:
                                      Title:

                            Amount of Investment: $75,000
                                                  ------------------------------

                            Number of Warrants  650,000
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       19
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By: /s/ Frank Elenio
                                            ------------------------------------
                                            Name:  Frank Elenio
                                            Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                      __________________________________________
                                      Name:

                            If an entity:

                                      Name of Entity: Commonwealth Investors LLC
                                                      --------------------------

                                      By: /s/ Authorized Signatory
                                          --------------------------------------
                                          Name:
                                          Title:

                            Amount of Investment: $45,000
                                                  ------------------------------

                            Number of Warrants 390,000
                                               ---------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       20
<PAGE>

         IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By: /s/ Frank Elenio
                                            ------------------------------------
                                            Name:  Frank Elenio
                                            Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                            /s/ Richard Konrad
                                            ------------------------------------
                                            Name:   Richard Konrad

                            If an entity:

                                        Name of Entity:_________________________

                                        By: ____________________________________
                                            Name:
                                            Title:

                            Amount of Investment: $50,000
                                                  ------------------------------

                            Number of Warrants 433,333
                                               ---------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       21
<PAGE>

         IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By: /s/ Frank Elenio
                                            ------------------------------------
                                            Name:  Frank Elenio
                                            Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                      __________________________________________
                                      Name:

                            If an entity:

                                     Name of Entity:  Merson Limited Partnership
                                                      --------------------------

                                     By: /s/ Authorized Signatory
                                         ---------------------------------------
                                         Name:
                                         Title:

                            Amount of Investment:  $50,000
                                                   -----------------------------

                            Number of Warrants  433,333
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       22
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             /s/ Richard Steinberg
                                             -----------------------------------
                                             Name:  Richard Steinberg

                            If an entity:

                                            Name of Entity: ____________________

                                            By: ________________________________
                                                Name:
                                                Title:

                            Amount of Investment:  $100,000
                                                   -----------------------------

                            Number of Warrants  866,667
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       23
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
                            If an individual:

                                            ____________________________________
                                            Name:

                            If an entity:

                                            Name of Entity: Trinad Capital, LP
                                                            --------------------

                                            By:  /s/ Authorized Signatory
                                                 -------------------------------
                                                 Name:
                                                 Title:

                            Amount of Investment:  $100,000
                                                   -----------------------------

                            Number of Warrants  866,667
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       24
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             /s/ Morry Kalimian
                                             -----------------------------------
                                             Name:  Morry Kalimian as Custodian
                                                    for Ariel Kalimian

                            If an entity:

                                             Name of Entity:____________________

                                             By:________________________________
                                                Name:
                                                Title:

                            Amount of Investment:  $50,000
                                                   -----------------------------

                            Number of Warrants  433,333
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       25
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                            /s/ Morry Kalimian
                                            ------------------------------------
                                            Name:   Morry Kalimian

                            If an entity:

                                            Name of Entity:_____________________

                                            By:_________________________________
                                               Name:
                                               Title:

                            Amount of Investment:  $100,000
                                                   -----------------------------

                            Number of Warrants  866,667
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       26
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             ___________________________________
                                             Name:

                            If an entity:

                                         Name of Entity:  Creekspan Partners, LP
                                                          ----------------------

                                         By: /s/ Authorized Signatory
                                             -----------------------------------
                                             Name:
                                             Title:

                            Amount of Investment:  $108,500
                                                   -----------------------------

                            Number of Warrants  940,333
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       27
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             /s/ Joshua Gessin
                                             -----------------------------------
                                             Name:   Joshua Gessin

                            If an entity:

                                            Name of Entity:_____________________

                                            By:_________________________________
                                               Name:
                                               Title:

                            Amount of Investment:  $50,000
                                                   -----------------------------

                            Number of Warrants  433,333
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       28
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             /s/ David Farnsworth
                                             -----------------------------------
                                             Name:   David Farnsworth

                            If an entity:

                                             Name of Entity:____________________

                                             By:________________________________
                                                Name:
                                                Title:

                            Amount of Investment:  $5,000
                                                   -----------------------------

                            Number of Warrants  43,333
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       29
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             /s/ Mark Kalimian
                                             -----------------------------------
                                             Name:   Mark Kalimian

                            If an entity:

                                             Name of Entity:____________________

                                             By:________________________________
                                                Name:
                                                Title:

                            Amount of Investment:  $150,000
                                                   -----------------------------

                            Number of Warrants  1,300,000
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       30
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             /s/ Jonathan J. Leifer
                                             -----------------------------------
                                             Name:   Jonathan J. Leifer

                            If an entity:

                                             Name of Entity:____________________

                                             By:________________________________
                                                Name:
                                                Title:

                            Amount of Investment:  $25,000
                                                   -----------------------------

                            Number of Warrants  216,667
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       31
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             ___________________________________
                                             Name:

                            If an entity:

                                        Name of Entity: DKR SoundShore Strategic
                                                        Holding Fund Ltd.
                                                        ------------------------

                                        By:  /s/ Authorized Signatory
                                             -----------------------------------
                                             Name:
                                             Title:

                            Amount of Investment:  $7,500
                                                   -----------------------------

                            Number of Warrants  65,000
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       32
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                             ___________________________________
                                             Name:

                            If an entity:

                                        Name of Entity: DKR SoundShore Oasis
                                                        Holding Fund Ltd.
                                                        ------------------------

                                        By:  /s/ Authorized Signatory
                                             -----------------------------------
                                             Name:
                                             Title:

                            Amount of Investment:  $142,500
                                                   -----------------------------

                            Number of Warrants  1,235,000
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       33
<PAGE>

      IN WITNESS WHEREOF, the parties have caused this Securities Purchase
Agreement to be duly executed and delivered as of the day and year first above
written. EXECUTION OF THIS AGREEMENT BY ANY INVESTOR SHALL BE DEEMED TO
CONSTITUTE EXECUTION OF THE REGISTRATION RIGHTS AGREEMENT BY SUCH INVESTOR.

                                        ROOMLINX, INC.

                                        By:  /s/ Frank Elenio
                                             -----------------------------------
                                             Name:  Frank Elenio
                                             Title: Chief Financial Officer

INVESTORS:
----------
                            If an individual:

                                            ____________________________________
                                            Name:

                            If an entity:

                                            Name of Entity:  Philippi Trading
                                                             -------------------

                                            By:  /s/ Authorized Signatory
                                                 -------------------------------
                                                 Name:
                                                 Title:

                            Amount of Investment:  $16,500
                                                   -----------------------------

                            Number of Warrants  143,000
                                                --------------------------------

                            Address of Investor:

                            ____________________________________________________

                            ____________________________________________________

                                       34

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00079-of-00352.parquet"}]]